This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Children who experienced sugar restrictions during their first 1,000 days after conception had up to 35% lower risk of developing type 2 diabetes and as much as 20% less risk of hypertension as adults. The researchers used contemporary data from the U.K. Biobank, a database of medical histories and genetic, lifestyle and other disease risk factors, to study the effect of those early-life sugar restrictions on health outcomes of adults conceived in the U.K. just before and after the end of wartim
In an investor presentation, executives hinted at the possibility of seeking an accelerated approval of trontinemab if it can significantly lower levels of amyloid in a Phase 3 trial.
Researchers have created the first blueprint of the human spliceosome, the most complex and intricate molecular machine in human biology. The vast majority of human genes -- more than nine in ten -- are edited by the spliceosome. The sheer number of components involved has meant the scientific feat took more than a decade to complete. The research reveals many new drug targets that could benefit a wide spectrum of diseases including most types of cancer, neurodegenerative conditions and genetic
THURSDAY, Oct. 31, 2024 -- Whooping cough is on the rise in the United States, with cases surging across the nation.It’s important to remember that whooping cough, also known as pertussis, can impact adults as well as kids, according to Infectious D.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
According to Bredt's rule, double bonds cannot exist at certain positions on organic molecules if the molecule's geometry deviates too far from what we learn in textbooks. This rule has constrained chemists for a century. Chemists have now shown how to make molecules that violate Bredt's rule, allowing chemists to find practical ways to make and use them in reactions.
The biotech expects three Phase 2 readouts in urticaria and eczema over the next two years, and will keep its “options open” regarding an IPO, its CEO said.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
The biotech expects three Phase 2 readouts in urticaria and eczema over the next two years, and will keep its “options open” regarding an IPO, its CEO said.
Echolocating bats have been found to possess an acoustic cognitive map of their home range, enabling them to navigate over kilometer-scale distances using echolocation alone.
THURSDAY, Oct. 31, 2024 -- Doctors in New York City are describing the first known U.S. cases of sexually transmitted ringworm, which can cause a nasty rash that can take months to bring under control.Despite the name, ringworm isn't any kind of.
Researchers have developed a model to calculate how quickly or slowly an organism should ideally learn in its surroundings. An organism's ideal learning rate depends on the pace of environmental change and its life cycle, they say.
THURSDAY, Oct. 31, 2024 -- Onions spread on McDonald's Quarter Pounders are the definite source of an outbreak of E. coli illness that's now affected 90 people nationwide, new evidence from the U.S. Centers for Disease Control and Prevention.
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
The immune disease drug developer expects to raise $300 million in a private financing set to close before its combination with the struggling Aerovate.
THURSDAY, Oct. 31, 2024 -- A new guidance issued jointly by groups representing U.S. surgeons, anesthesiologists and gastroenterologists affirms that most people taking popular GLP-1 weight-loss meds can keep taking them in the weeks before a.
Patient advocates are hoping for change under new director Michelle Tarver, while industry groups hope she will build on former director Jeff Shuren’s leadership.
THURSDAY, Oct. 31, 2024 -- Amid an ongoing outbreak of bird flu in poultry and dairy cows in the United States, a case of H5N1 has now been confirmed for the first time in a pig."The U.S. Department of Agriculture [USDA] and Oregon state veterinary.
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
THURSDAY, Oct. 31, 2024 -- Don’t automatically throw out that old COVID-19 at-home test you just came across in your medicine cabinet.It might still be good, according to the U.S. Food and Drug Administration.Some over-the-counter COVID tests have h.
THURSDAY, Oct. 31, 2024 -- If anxiety over this year’s presidential election is keeping you up at night, you’re not alone.About 17% of all U.S. adults -- a striking 45 million Americans -- say the election has negatively impacted their sleep, acc.
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
If you’re looking for an antibody that works for your experiment, you may be overwhelmed by options — or not know where to start looking to find one. Luckily, there are websites that can help: Antibody data repositories, which share validation data, and antibody search engines, which allow you to search many different antibody catalogs at the same time.
THURSDAY, Oct. 31, 2024 -- A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 2021 that same patient spent $2,378 annually, a new report finds.Out-of-pocket costs for drugs for.
The Impact of Enzymatic DNA Synthesis on Compact Protein Circuitry for Regulating Protein Secretion Across Multiple Levels of the Central Dogma pesurya Thu, 10/31/2024 - 12:03 Tue, 12/10/2024 - 12:00 Resource Type Webinar Dan Lin-Arlow Connor Clayton Call Promotion Start Mon, 11/04/2024 - 08:30 Promotion End Sun, 05/04/2025 - 08:30 Duration 60 Minutes In recent decades, mammalian synthetic biology has shown that key principles of biological regulation can be rewritten to control gene expression
THURSDAY, Oct. 31, 2024 -- In a finding that challenges conventional thinking on when people with failing heart valves but no symptoms should get surgery, a new study suggests these patients would fare far better if they had their valves replaced.
As the pharmaceutical industry continues to evolve, drug developers encounter new challenges and opportunities in their pursuit of innovation. From adapting to complex new trial designs to embracing cutting-edge technologies, staying ahead requires a deep understanding of the current landscape. In response, the PPD clinical research business of Thermo Fisher Scientific conducted its third global survey of 150 drug developers to capture a comprehensive view of these evolving trends.
THURSDAY, Oct. 31, 2024 -- Scans using lasers and ultrasound can pick up signs of a malaria infection through the skin, without the need for a blood draw, Yale researchers report.The technology, called Cytophone, could be a real boon for developing.
THURSDAY, Oct. 31, 2024 -- Sugar overload is a real danger on Halloween, as piles of candy prove a powerful temptation to both Trick-or-Treaters and the folks handing out the goodies.Too many sweet treats can instigate a blood sugar spike followed.
A Comparative Genomics Strategy To Discover Mechanisms of Cellular Resilience By Rose Circeo October 31, 2024 Breadcrumb Home A Comparative Genomics Strategy To Discover Mechanisms of Cellular Resilience The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease. Experts from across the Medical and Population Genetics community at the Broad Institute give in-depth introductions to research in human genetics through ove
THURSDAY, Oct. 31, 2024 -- The COVID-19 pandemic appears to have created a nation of homebodies in the United States, a new study finds.People are spending nearly an hour less each day doing activities outside the home, researchers reported Oct. 31.
Welcome to our new blog series on a REPROCELL 3D tissue engineering platform powered by Alvetex® technology. This series aims to inform and educate the research community and industry partners about the significance and benefits of cutting-edge bioengineered 3D human tissue model systems, which may be instrumental in facilitating translational research studies and accelerating the development of drugs and products.
THURSDAY, Oct. 31, 2024 -- When a black cat named Pepper dropped a dead mouse on the carpet at his owner's feet on a day back in May 2021, neither of them knew then that it would alert scientists to the arrival of an exotic virus to the United.
Scientists investigating animal viruses with potential to infect humans have identified a critical protein that could enable spillover of a family of organisms called arteriviruses. In a new study, researchers identified a protein in mammals that welcomes arteriviruses into host cells to start an infection. The team also found that an existing monoclonal antibody that binds to this protein protects cells from viral infection.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
319 
Let's personalize your content